Company Portfolio

Kite Pharma

Patents indexed

Year range

2026

biotechpharmaceuticalgene_editingimmunotherapy

Key Inventors

John Rossi1 Adrian Bot1

All Patents

Career timeline

1 patents, in 2026

Dot size = forward citations

Hover or tap any dot to see the patent. Larger dots indicate more forward citations — a proxy for downstream influence.

2026 — Treating a Specific Lymphoma with Modified T Cells

US 12600775·2026

Treating a Specific Lymphoma with Modified T Cells

This patent describes a method to treat a difficult-to-treat type of lymphoma by taking a patient's own immune cells, modifying them to recognize and attack cancer, and then giving them back to the patient.

Patent monitoring

Kite Pharma

1 patents, in 2026

Get notified when Kite Pharma files a new patent